Connect with us

Press Release

Daniel Tuffy Highlights Everyday Health System Trends People Can No Longer Ignore

Published

on

Daniel Tuffy is a senior healthcare executive based in Gainesville, Georgia, focused on access to care, ambulatory services, and building healthier cultures for patients and providers.

Georgia, US, 3rd February 2026, ZEX PR WIRE, Senior healthcare executive Daniel Tuffy is calling attention to several trends that are quietly reshaping how individuals experience the health system. Drawing on more than two decades leading large physician groups and service lines, he is urging people to look beyond headlines and understand how access, burnout, and care settings are changing the day to day reality of getting help when they need it.

Across the United States, many people still struggle to get timely appointments with primary and specialty care. In recent national surveys, roughly 3 in 10 adults report delaying or skipping care due to cost, scheduling barriers, or logistical challenges. At the same time, ambulatory and outpatient surgery centers are taking on a growing share of procedures that used to be done only in hospitals, often at lower cost and with shorter recovery times.

Provider burnout is another trend that has moved from internal concern to public issue. Large professional associations and workforce studies consistently show that a significant share of physicians and nurses report high levels of emotional exhaustion and stress. This affects not only the people providing care but also access, continuity, and patient satisfaction.

Tuffy summarizes these shifts this way: access to the right care, in the right setting, with teams that are supported to do their best work is no longer a nice to have. It is now the baseline expectation individuals should look for when they navigate the system. When those pieces are missing, people feel it through long waits, rushed visits, and confusion about what comes next.

He notes that ambulatory surgery growth, improved scheduling systems, and virtual visits can all work in favor of patients if they are designed thoughtfully. But he also points out that technology and new buildings alone do not fix the core issues if organizations do not address workflows, communication, and the day to day barriers that wear clinicians down.

For individuals and families, the practical takeaway is simple: pay attention to how your providers and organizations talk about access, burnout, and quality. When leaders are transparent about these topics and share clear steps they are taking to improve them, it often signals a culture that is serious about long term performance rather than quick fixes.

Your Next 7 Days

These are small, concrete steps people can take in the next week to put these trends to work in their own lives.

  1. Make a list of your care team
    Write down the names, contact information and locations of your primary care provider, any specialists, and urgent care or ambulatory centers you might use. Knowing your options before you are sick shortens delays when something happens.

  2. Check access and after hours options
    Look up office hours, same day appointment policies, nurse advice lines, and virtual visit options. Save key phone numbers in your phone so you are not searching under stress.

  3. Review your upcoming health needs
    Think about routine screenings, follow ups, or refills you are likely to need in the next three to six months. Schedule at least one of them this week so you are not competing for last minute slots later.

  4. Ask one question about quality
    At your next visit, ask how the clinic measures patient experience or outcomes. You are not looking for a perfect score, only for a clear, honest answer about what they track and how they use it.

  5. Notice staff workload and communication
    Pay attention to how frontline staff interact with each other and with you. Calm, coordinated teams usually reflect better systems behind the scenes. If everything feels chaotic all the time, that can be a signal to plan for alternatives when possible.

  6. Set up your patient portal
    If your provider offers an online portal, sign up and log in. Portals can make it easier to request refills, see test results, and send non urgent questions without long phone waits.

  7. Talk with family about an emergency plan
    Spend ten minutes agreeing on where you would go for urgent needs, who would drive, and what information you would bring. A simple plan reduces stress in real emergencies and makes better use of healthcare resources.

Your Next 90 Days

Over the next three months, longer actions can help you build a more resilient relationship with the health system.

  1. Establish or reconnect with your primary care
    If you do not have a primary care provider, prioritize finding one in the next 90 days. If you do, schedule an annual visit or check in. Strong relationships in primary care improve access and coordination when problems arise.

  2. Compare care settings for common procedures
    If you know a surgery or procedure is coming, ask where it can be done. In many cases, ambulatory surgery centers offer safe, high quality care at lower cost and with more flexible scheduling. Understanding your options helps you make informed choices.

  3. Organize your health information
    Create a simple folder, digital or paper, with your medication list, major diagnoses, surgeries, allergies, and key contacts. Having this ready makes every visit smoother and reduces the chance of errors.

  4. Assess your providers’ communication style
    Over several visits, notice whether your care team explains next steps clearly, involves you in decisions, and follows up when they say they will. If the pattern does not support trust, consider whether a different provider or organization might be a better fit over the long term.

  5. Support staff and clinicians where you can
    Small actions such as arriving on time, using portals for routine questions, and offering specific feedback when something goes well help reduce friction. In a system where burnout is common, being a constructive partner in your own care can make a real difference at the margins.

Tuffy’s perspective is shaped by years overseeing clinical operations, budgets, and patient experience across large ambulatory and acute care networks. He emphasizes that the trends facing healthcare today are not abstract policy debates. They show up as the time it takes to get an appointment, the tone in the exam room, and the clarity you feel when you leave a visit.

For individuals, the goal is not to control the whole system. It is to understand where it is moving and take practical steps to protect access, quality, and continuity for themselves and their families.

Pick one step from the lists above and complete it this week. Small, deliberate moves today make it easier to navigate a complex health system tomorrow.

About Daniel Tuffy
Daniel Tuffy is a senior healthcare executive based in Gainesville, Georgia, with more than 20 years of experience leading strategic, operational, and clinical transformation across large health systems and physician groups. His work has focused on expanding access to ambulatory care, improving patient and provider experience, and building high performance cultures that support safe, high quality care.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

CMS(867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity

Published

on

SHENZHEN, CHINA China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that self-developed innovative drug INHBE-targeting small nucleic acid drug CMS-D008 injection (“CMS-D008”) received the Drug Clinical Trial Approval Notice issued by National Medical Products Administration (“NMPA”) on 4 March 2026. The NMPA has approved the conduct of clinical trials of CMS-D008 injection for overweight or obese individuals.

About CMS-D008

CMS-D008 is a novel siRNA therapy administered by subcutaneous injection. CMS-D008 targets and reduces the hepatic expression of the inhibin subunit beta E (INHBE) gene and lowers the level of Activin E protein encoded by INHBE, which blocks Activin E-ALK7 signaling and reduces fat accumulation effectively. Preclinical studies suggested that CMS-D008 efficiently and sustainably suppressed INHBE expression. In the diet-induced obesity model, CMS-D008 enhanced weight loss by reducing fat mass while retaining lean mass with a good safety profile. It demonstrates potentially better prospects for high-quality, long-term weight loss that boosts fat-specific loss while preserving muscle mass. In the future, it may be developed for the treatment of overweight/obesity, abdominal obesity, and related metabolic diseases.

Fat Loss, muscle preserved: a potentially better therapeutic option for overweight/obesity

Overweight or obesity is a chronic, progressive, relapsing disease characterized by excessive accumulation or abnormal distribution or function of body fat[1]. World Obesity Atlas 2025 Report projected that the global proportion of overweight and obese adults will rise to 50%, with nearly 3 billion adults impacted by high body mass index (BMI), and the population of adults who are overweight or obese in China is projected to reach 515 million by 2030[2]. Existing GLP-1RAs have been proven to be effective for the treatment of overweight and obesity. The main actions of GLP-1RAs are to suppress appetite by acting on the central nervous system and to delay gastric emptying[3]. INHBE’s novel mechanism of action differs from GLP-1RAs. INHBE is identified through genome-wide association studies. Populations with loss of function in INHBE are associated with favorable fat distribution and beneficial metabolic characteristics[4]. Targeted inhibition of INHBE might be more conducive for long-term weight management at the genetic level with precisely lower visceral fat and favorable metabolic profiles.

CMS-D008 teams up with CMS-D005: highly effective weight loss plus long-term maintenance, building a more comprehensive weight-loss solution

CMS-D008 will synergize with CMS-D005, a self-developed innovative drug currently in clinical development. CMS-D008 reduces fat without sacrificing muscle mass by precisely inhibiting INHBE gene expression; while CMS-D005, as a GLP-1R/GCGR dual agonist, can effectively reduce liver fat while losing weight. The synergy between these two drugs will achieve highly effective weight loss benefits and long-term maintenance of results, jointly enhancing the Group’s R&D capabilities and product competitiveness in the field of obesity/metabolic treatment. Furthermore, leveraging the Group’s mature network resources in the field of cardiovascular and metabolic diseases, the drug’s R&D and commercialization process will be accelerated, providing patients with more comprehensive and innovative treatment options.

The Group is actively preparing to initiate relevant clinical trials and strives to launch the Product as soon as possible.

About CMS

CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.

CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.

CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardiovascular-kidney-metabolic/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.

Reference:

  1. Chinese Society of Endocrinology. Guideline for chronic weight management and clinical practice of anti-obesity medications(2024 version). Chinese Journal of Endocrinology and Metabolism. 2024,40(7):545-564.
  2. World Obesity Federation. World Obesity Atlas 2025. London: World Obesity Federation, 2025. https://data.worldobesity.org/publications/?cat=23
  3. Zhikai Zheng, Yao Zong, Yiyang Ma, Yucheng Tian, Yidan Pang, Changqing Zhang, Junjie Gao. Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Sig Transduct Target Ther 9, 234 (2024). doi: 10.1038/s41392-024-01931-z
  4. Parsa Akbari, Olukayode A Sosina, Jonas Bovijn, et al. Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes. Nat Commun.2022 Aug 23;13(1):4844. doi: 10.1038/s41467-022-32398-7.

CMS Disclaimer and Forward-Looking Statements

This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.

This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.

Media Contact

Brand: China Medical System Holdings Ltd.

Contact: CMS Investor Relations

Email: ir@cms.net.cn

Website: https://web.cms.net.cn/en/home/

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Oberheiden P.C. Now Offering Nevada Asset Protection Trusts

Published

on

United States, 5th Mar 2026 – Oberheiden P.C. is pleased to announce that the firm’s asset protection attorneys are now offering Nevada asset protection trusts to clients nationwide. Nevada asset protection trusts are unique among domestic asset protection trusts (DAPTs) for their flexibility, and they can be powerful tools for insulating high-net-worth individuals’ assets from creditor claims both in and out of court.

According to the firm’s founding attorney, Dr. Nick Oberheiden, “While many high-net-worth individuals are familiar with the benefits afforded by offshore asset protection trusts, far fewer are familiar with the domestic options that are available. The Nevada asset protection trust can be a particularly good option for individuals who want to protect their assets within the United States while also taking advantage of the estate planning, tax planning, and other benefits that domestic trusts can afford.”

Dr. Oberheiden says that forming Nevada asset protection trust can be a particularly good option for several reasons. For example, while a Nevada asset protection trust is a type of irrevocable trust, a grantor (the individual who forms a trust) still has the ability to modify how they hold their assets over time. This distinguishes Nevada law from the laws of many other states. Nevada also has a shorter statute of limitations for creditor claims than most other states (two years in most cases), and Nevada law does not recognize any exception creditors.

“These factors, combined with the relative ease of forming a Nevada domestic asset protection trust, make using a Nevada DAPT a desirable option in a wide range of circumstances—including circumstances in which high-net-worth individuals might otherwise be looking at transferring assets into an offshore trust established in the Cook Islands or another foreign jurisdiction.” Dr. Oberheiden continues, “If you are interested in learning about your options for protecting your wealth from both known and unknown creditors, it will be worth talking to an attorney about whether a Nevada DAPT is a good option for your individual circumstances.”

While forming a Nevada DAPT involves leveraging the benefits afforded under the state’s trust laws, Dr. Oberheiden emphasizes that this is not solely an option for Nevada residents. “When the Nevada legislature adopted the state’s asset protection trust laws, it specifically opened up the possibility of forming a Nevada DAPT to individuals residing across the country. Although there are certain statutory requirements that make it important to work with a Nevada trust company, individuals nationwide can form statutory trusts in Nevada for asset protection purposes.”

Dr. Oberheiden is also quick to emphasize that while forming a Nevada DAPT is a desirable option in many cases, it is important for all high-net-worth individuals to make informed decisions about their asset protection needs based on their individual circumstances. “While forming a Nevada DAPT to protect real property and other assets will make sense for many individuals, it is important to consider the other options that are available as well. A few states offer self-settled spendthrift trust options that will meet individuals’ needs in some cases; and, in other cases, forming an offshore asset protection trust may be necessary to protect assets located around the world.”

“Additionally,” he continues, “limited liability companies and other vehicles can be used for asset protection as well. Purchasing liability insurance can be a cost-effective means of limiting high-net-worth individuals’ personal liability exposure as well. Ultimately, while we are now offering Nevada asset protection trusts, we are still focused on ensuring that we provide each of our clients with a custom-tailored solution focused on their specific risks and needs.”

Dr. Oberheiden says that high-net-worth individuals who are interested in learning about the options for safeguarding their assets in the U.S. and abroad are encouraged to contact the firm for a complimentary initial consultation. “We have a team of highly skilled asset protection attorneys who are committed to helping our clients protect their assets not only in the short term, but also for future generations.” He continues, “If you have questions, one of our attorneys will be more than happy to schedule a call to begin talking through your options in strict confidence.”

Nick OberheidenFounding Attorney, 888-680-1745 (Office)

Attorney Advertising – Oberheiden, P.C., is an asset protection law firm headquartered in Houston, TX with a nationwide network of senior attorneys and consultants. The firm’s asset protection attorneys are available to assist clients with Nevada asset protection trusts and other asset protection strategies throughout the United States. The firm’s addresses and contact information can be found at www.federal-lawyer.com/our-locations.

 

Media Contact

Organization: Oberheiden, P.C.

Contact Person: Nick Oberheiden, Founding Attorney

Website: https://federal-lawyer.com/asset-protection/

Email: Send Email

Contact Number: +18886801745

Country:United States

Release id:42208

Disclaimer: This press release is provided for general informational purposes only and does not constitute legal, financial, or professional advice.

The post Oberheiden P.C. Now Offering Nevada Asset Protection Trusts appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

SPL VPN Announces AI-Driven Architectural Shift to Replace Manual Server Routing

Published

on

Dubai, UAE, 5th March 2026, ZEX PR WIRE, SPL VPN has announced an architectural transition to an AI-driven routing engine, effectively automating global server selection for its two million users. The shift replaces traditional manual configurations with a proprietary protocol designed to eliminate connection guesswork and latency issues.

As digital privacy requirements evolve, SPL VPN is prioritizing usability through a system that analyzes network congestion, ISP throttling, and packet loss in real-time. This “zero-touch” approach automatically builds optimized routes for specific traffic types, such as streaming or secure browsing, without user intervention.

The update features predictive reconnection technology, allowing the infrastructure to anticipate node failures and switch paths before a connection drop occurs. This technical advancement is reflected in the platform’s new adaptive interface, which simplifies the experience for over 500,000 daily active users by removing legacy server lists.

“The future of connectivity is a seamless layer that functions before the user identifies a need for it,” stated the Head of Product at SPL. “After eight years of development, we are moving beyond the industry’s traditional ‘server-count race’ toward a model of delivery intelligence.”

Established in 2018, SPL VPN has consistently combined encryption standards with emerging AI research. This latest expansion strengthens the company’s position as a utility-focused provider for the modern web, offering a faster and more intuitive framework for global digital security.

About SPL VPN

SPL VPN is a global provider of digital privacy solutions. Established in 2018 in Singapore, the company utilizes AI-driven routing and military-grade encryption to provide secure, high-performance internet access for over 2 million users worldwide.

Website: https://splvpn.com/

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST